Table 1 Antimicrobial susceptibility testing results
From: Genomic and phenotypic analysis of a novel clinical isolate of Corynebacterium pyruviciproducens
Antimicrobial class | Antimicrobial agenta | Result for the strain ATCC BAA-1742Â T | Result for the strain WYJY-01 | ||
|---|---|---|---|---|---|
MIC (μg·mL−1) | Interpretationb | MIC (μg·mL−1) | Interpretation | ||
Penicillins | Penicillin | 0.094 | S | 2 | I |
Penicillins | Ampicillin | NDc | Â | 0.5 | NB |
Penicillins | Amoxicillin-clavulanic acid | 0.094 | NB | ND | Â |
Penicillins | Piperacillin-tazobactam | 0.5 | S | ND | Â |
Cephems | Cefotaxime | ND | Â | 0.5 | S |
Cephems | Ceftriaxone | 1.5 | I | 4 | R |
Cephems | Cefuroxime | 0.125 | NB | ND | Â |
Cephems | Cefepime | 0.25 | S | ND | Â |
Carbapenems | Imipenem | 0.064 | S | 0.25 | S |
Glycopeptides | Vancomycin | 0.38 | S | 1 | S |
Lipopeptides | Daptomycin | 0.032 | S | ND | Â |
Aminoglycosides | Gentamicin | 0.25 | S |  > 256 | R |
Macrolides | Erythromycin | 2 | R |  > 256 | R |
Quinolones | Levofloxacin | ND |  |  > 32 | NB |
Quinolones | Ciprofloxacin | 0.19 | S |  > 32 | R |
Quinolones | Moxifloxacin | 0.064 | NB | ND | Â |
Tetracyclines | Tetracycline | 0.75 | S | 0.5 | S |
Tetracyclines | Tigecycline | 0.032 | NB | ND | Â |
Lincosamides | Clindamycin |  > 256 | R |  > 256 | R |
Folate pathway inhibitors | Trimethoprim-sulfamethoxazole | ND | Â | 1 | S |
Ansamycins | Rifampin |  < 0.002 | S | 0.125 | S |
Oxazolidinones | Linezolid | 0.38 | S | 0.25 | S |
Oxazolidinones | Linezolid | 0.38 | S | 0.125 | S |